Publications of Yvonne Genzel
All genres
Journal Article (92)
1.
Journal Article
259, 104544 (2022)
Absolute quantification of viral proteins during single-round replication of MDCK suspension cells. Journal of Proteomics 2.
Journal Article
10 (2), 249 (2022)
High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density Bioreactor. Vaccines 3.
Journal Article
12 (3), 239 (2022)
Impact of Influenza A Virus Infection on Growth and Metabolism of Suspension MDCK Cells Using a Dynamic Model. Metabolites 4.
Journal Article
118 (10), pp. 3996 - 4013 (2021)
Towards integrated production of an influenza A vaccine candidate with MDCK suspension cells. Biotechnology and Bioengineering 5.
Journal Article
118 (12), pp. 4720 - 4734 (2021)
A high cell density perfusion process for Modified Vaccinia virus Ankara production: process integration with inline DNA digestion and cost analysis. Biotechnology and Bioengineering 6.
Journal Article
16 (1), e2000024 (2021)
Production of Modified Vaccinia Ankara Virus by Intensified Cell Cultures: A Comparison of Platform Technologies for Viral Vector Production. Biotechnology Journal 7.
Journal Article
19 (1), 91 (2021)
Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles. BMC Biology 8.
Journal Article
105, pp. 7251 - 7264 (2021)
Cell culture–based production of defective interfering influenza A virus particles in perfusion mode using an alternating tangential flow filtration system. Applied Microbiology and Biotechnology 9.
Journal Article
105 (1), pp. 129 - 146 (2021)
OP7, a novel influenza A virus defective interfering particle: production, purification, and animal experiments demonstrating antiviral potential. Applied Microbiology and Biotechnology 10.
Journal Article
9 (7), 706 (2021)
SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor. Vaccines 11.
Journal Article
105 (5), pp. 1861 - 1874 (2021)
Tracking changes in adaptation to suspension growth for MDCK cells: cell growth correlates with levels of metabolites, enzymes and proteins. Applied Microbiology and Biotechnology 12.
Journal Article
95 (24), e01174-21 (2021)
Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapy. Journal of Virology 13.
Journal Article
288 (16), pp. 4869 - 4891 (2021)
Comprehensive N‐glycosylation analysis of the influenza A virus proteins HA and NA from adherent and suspension MDCK cells. The FEBS Journal 14.
Journal Article
11 (1), 5147 (2021)
Site-specific N-glycosylation analysis of animal cell culture-derived Zika virus proteins. Scientific Reports 15.
Journal Article
105 (4), pp. 1421 - 1434 (2021)
High cell density perfusion process for high yield of influenza A virus production using MDCK suspension cells. Applied Microbiology and Biotechnology 16.
Journal Article
8, 672 (2020)
Application of an Inclined Settler for Cell Culture-Based Influenza A Virus Production in Perfusion Mode. Frontiers in Bioengineering and Biotechnology 17.
Journal Article
104 (11), pp. 4877 - 4888 (2020)
Performance of an Acoustic Settler Versus a Hollow Fiber-Based ATF Technology for Influenza Virus Production in Perfusion. Applied Microbiology and Biotechnology 18.
Journal Article
117 (10), pp. 3040 - 3052 (2020)
Virus harvesting in perfusion culture: Choosing the right typeof hollow fiber membrane. Biotechnology and Bioengineering 19.
Journal Article
117 (5), pp. 1533 - 1553 (2020)
A dynamic model linking cell growth to intracellular metabolism and extracellular by‐product accumulation. Biotechnology and Bioengineering 20.
Journal Article
21 (17), 6111 (2020)
Cell Bank Origin of MDCK Parental Cells Shapes Adaptation to Serum-Free Suspension Culture and Canine Adenoviral Vector Production. International Journal of Molecular Sciences